Topical mupirocin helps reduce inflammation in lupus, offering a potential new approach for managing symptoms and improving ...

Lupus can cause hearing loss. This is often due to inflammation or immune responses affecting the inner ear. Symptoms can ...

EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.

Your gut microbiome can trigger an immune response, leading to chronic systemic inflammation and lupus. Here are some tips to ...

Objectives To investigate the effect of Benson relaxation response technique (BRRT) on the quality of life (QOL) among patients with systemic lupus erythematous (SLE). Methodology A quasi-experimental ...

Systemic Lupus Erythematosus (SLE)-lupus for short-is a chronic, painful and debilitating disease in which the antibodies produced by the immune system mistakenly attack the body's own tissues.

Results showed that systemic lupus carries the greatest risk for heart health ... can counsel patients regarding the importance of a heart-healthy lifestyle including diet, exercise, and smoking ...

Systemic Lupus Erythematosus (SLE)—lupus for short—is a chronic, painful and debilitating disease in which the antibodies produced by the immune system mistakenly attack the body's own tissues.

Another older case report indicates that people with lupus panniculitis may have mild or no systemic symptoms. Scientists do not yet know the exact cause of lupus panniculitis. It could occur due ...

A person may need to take antibiotics to treat skin infections. People who inherit CHLE are unlikely to develop systemic lupus erythematosus (SLE). However, if CHLE spontaneously occurs later in ...

In addition, 19 juvenile systemic sclerosis (jSSc) and 25 age-matched healthy children were selected as patient control and healthy control, respectively. Results Serum NF-κB levels in patients with ...

In the Phase 2b CARE study, the investigational drug, cenerimod, demonstrated safe and effective results for treatment of adults with moderate-to-severe systemic lupus erythematosus (SLE). The drug’s ...